Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
The New England Journal of Medicine|July 30, 2004
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected personsRaymond T Chung, Janet Andersen, Paul Volberding, et al.
JAMA Cardiology|December 13, 2023
Mineralocorticoid Receptor Antagonism by Eplerenone and Arterial Inflammation in HIV: The MIRABELLA HIV StudySuman Srinivasa, Shady Abohashem, Allie R Walpert, et al.
The Lancet. HIV|September 24, 2016
Cognitive behavioural therapy for adherence and depression in patients with HIV: a three-arm randomised controlled trialSteven A Safren, C Andres Bedoya, Conall O'Cleirigh, et al.
The Journal of Infectious Diseases|July 29, 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyHeather J Ribaudo, Huan Liu, Matthias Schwab, et al.
Gastroenterology|September 14, 2004
High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infectionGeorg M Lauer, Eleanor Barnes, Michaela Lucas, et al.
The Journal of Experimental Medicine|September 24, 2004
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cellsMathias Lichterfeld, Daniel E Kaufmann, Xu G Yu, et al.
Hepatology (Baltimore, Md.)|February 22, 2023
Burden of fatty liver and hepatic fibrosis in persons with HIV: A diverse cross-sectional US multicenter studySamer Gawrieh, Jordan E Lake, Paula Debroy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infectionSigall Kassutto, Kaveh Maghsoudi, Mary N Johnston, et al.
The Journal of Clinical Investigation|September 17, 2003
Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramersCheryl L Day, Nilufer P Seth, Michaela Lucas, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2013
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testingGeorge L Melikian, Soo-Yon Rhee, Vici Varghese, et al.
Pageof 12